-
Company Insights
New![]()
Innovation and Patenting activity of Just Eat Takeawaycom NV Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Just Eat Takeawaycom NV Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ketamine in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ketamine in Binge Eating Disorder Drug Details:Ketamine is under development for the treatment of alcohol use...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Binge Eating Disorder Drug Details: Psilocybin (TRP-8802) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NOE-115 in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. NOE-115 in Binge Eating Disorder Drug Details: NOE-115 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMB-101 in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BMB-101 in Binge Eating Disorder Drug Details:BMA-101 is under development for the treatment of undisclosed seizure...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1.4979 in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1.4979 in Binge Eating Disorder Drug Details: BP-1.4979 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Binge Eating Disorder Drug Details: Oxytocin (TI-001) is under development for the treatment...
-
Analyst Opinions
![]()
Will Foodservice Win or Lose in the Game of Eat in or Go out?
Foodservice TrendSights Report Overview Many consumers prefer dining out compared to eating at home due to the superior quality of menu items. Food service providers need to find a balance between affordability and quality. This is because consumers are becoming more price-conscious but maintain expectations of the quality of menu items while dining out. The “Will Foodservice Win or Lose in the Game of Eat in or Go Out” research report analyzes trends explored on GlobalData's TrendSights Map. The consumer...
-
Company Profile
![]()
Eat JUST, Inc. – Company Profile
Eat JUST, Inc., known widely as JUST, is a US-based food manufacturing company headquartered in San Francisco that produces plant-based foods that are sold internationally.
Add to Basket -
Sector Analysis
![]()
United Kingdom (UK) Home Outdoor Eating Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer - Outdoor eating 2023 report offers a comprehensive insight into consumer attitudes in the UK outdoor eating market. The report focuses on four key subcategories: overall outdoor eating, barbeques, barbeque cooking tools and utensils, and picnicware. Consumer data is based on our 2023 UK outdoor eating survey, using a panel of 2,000 nationally representative consumers.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.